PGT Innovations and John Cannon Homes Ink Exclusive Partnership Agreement

NORTH VENICE, Fla.–(BUSINESS WIRE)–PGT Innovations (NYSE: PGTI), a national leader in the premium window and door category, has penned an exclusive partnership deal with southwest Florida’s premier luxury builder John Cannon Homes. PGT Innovations will provide windows and doors from… Read morePGT Innovations and John Cannon Homes Ink Exclusive Partnership Agreement

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against First American Financial Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of First American Financial Corp. (“First American” or “the Company”) (NYSE: FAF) for violations of §§10(b) and 20(a)… Read moreINVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against First American Financial Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Advanced Drainage Systems, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, Aug. 22, 2019 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors who purchased common stock, or derivative securities convertible into, exercisable for, or… Read moreONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Advanced Drainage Systems, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Myriad Genetics, Inc. (“Myriad” or “the Company”) (NASDAQ: MYGN) for violations of §§10(b) and 20(a) of the… Read moreINVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Keeping Governing Boards Accountable & On Track: NXTBoard and Brown Dog Consulting Partner to Help Leadership Teams and Governing Boards Excel

AUSTIN, Texas and OTTAWA, Aug. 22, 2019 (GLOBE NEWSWIRE) — NXTBoard, the Austin-based board management technology company, is partnering with the governance education firm, Brown Dog Consulting, to boost boards of directors’ ability to perform successfully over the long-term.NXTBoard is… Read moreKeeping Governing Boards Accountable & On Track: NXTBoard and Brown Dog Consulting Partner to Help Leadership Teams and Governing Boards Excel

Viveve Signs Exclusive Distribution Partnership in Canada with Salient Medical Solutions

Viveve Medical, Inc. Companies Mentioned: Primary Exchange: NASDAQUnder the Symbol: VIVE $0.0084 7.39% Thursday, August 22, 2019 8:28 AM Company Expands North America Commercial Capabilities ENGLEWOOD, CO / ACCESSWIRE / August 22, 2019 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical… Read moreViveve Signs Exclusive Distribution Partnership in Canada with Salient Medical Solutions

VisionGate Announces an Exclusive Global License, Manufacturing and Supply Agreement for Iloprost, VisionGate’s Phase 2 Oral Lung Cancer Interception Drug

Seattle, WA, Aug. 22, 2019 (GLOBE NEWSWIRE) —VisionGate, Inc., a clinical stage oncology pharmaceutical and diagnostics company, announces that it has finalized an exclusive worldwide license agreement regarding iloprost betadex clathrate and a manufacturing and supply agreement for the substance… Read moreVisionGate Announces an Exclusive Global License, Manufacturing and Supply Agreement for Iloprost, VisionGate’s Phase 2 Oral Lung Cancer Interception Drug

Ebix Powered PPL Exchange Helps Lloyd’s, London Market Insurers Surpass Q2 Electronic Placing Targets

JOHNS CREEK, Ga., Aug. 22, 2019 (GLOBE NEWSWIRE) — Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, healthcare and e-learning industries announced that the Ebix powered Exchange Platform Placing Ltd…. Read moreEbix Powered PPL Exchange Helps Lloyd’s, London Market Insurers Surpass Q2 Electronic Placing Targets

Navigant Research Report Finds the Global Market for Advanced Traffic Management Is Expected to Exceed $1 Billion This Year

BOULDER, Colo.–(BUSINESS WIRE)–A new report from Navigant Research analyzes the ongoing transformation occurring in the traffic management industry, providing global market forecasts, segmented by region and technology, through 2028. Advanced traffic management systems (ATMSs) such as adaptive traffic control (ATC)… Read moreNavigant Research Report Finds the Global Market for Advanced Traffic Management Is Expected to Exceed $1 Billion This Year

Tech Data Introduces Contracts Exchange Program to Help Partners Better Serve the Public Sector

CLEARWATER, Fla.–(BUSINESS WIRE)–Tech Data (Nasdaq:TECD) today announced a new Contracts Exchange Program (CEP) that will help its public sector customers reduce the cost, resources, time constraints and long procurement cycles typically associated with serving as a primary resource or sub-contractor… Read moreTech Data Introduces Contracts Exchange Program to Help Partners Better Serve the Public Sector

Themis Bioscience Announces Exclusive License and Research Collaboration Agreement with MSD to Develop Vaccine Candidates

VIENNA–(BUSINESS WIRE)–Themis Bioscience announced today a research collaboration and exclusive license agreement with MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA) for the discovery and development of undisclosed vaccine candidates using Themis’ measles virus vector-based platform. “Given the… Read moreThemis Bioscience Announces Exclusive License and Research Collaboration Agreement with MSD to Develop Vaccine Candidates

Mastercard Expands Global Relationship With Riot Games as Exclusive Category Partner of League of Legends® Championship Series in North America

PURCHASE, N.Y.–(BUSINESS WIRE)–Mastercard today announced it has expanded its existing, global partnership with Riot Games League of Legends esports into financial services category exclusivity for the League of Legends Championship Series (LCS), the preeminent esports series in North America, deepening… Read moreMastercard Expands Global Relationship With Riot Games as Exclusive Category Partner of League of Legends® Championship Series in North America

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Myriad Genetics, Inc. (“Myriad” or “the Company”) (NASDAQ: MYGN) for violations of §§10(b) and 20(a) of the… Read moreINVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nektar Therapeutics and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Nektar Therapeutics (“Nektar” or “the Company”) (NASDAQ: NKTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934… Read moreIMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nektar Therapeutics and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Valaris plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Valaris plc (“Valaris” or “the Company”) (NYSE: VAL) for violations of §§10(b) and 20(a) of the Securities Exchange Act… Read moreIMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Valaris plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm